|
Type 2 inflammation in asthma — present in most, absent in many
Nature.com In the version of this article that was originally published, the targeted epitope of lebrikizumab was listed as "IL?4R?" in Table 1 but this should be "IL?13 (IL?4Rz??binding epitope)". Also, for the main effects of lebrikizumab in human asthma trials … |
View full post on asthma – Google News